BONETTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 3.867
EU - Europa 3.695
AS - Asia 2.195
SA - Sud America 281
AF - Africa 49
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 10.110
Nazione #
US - Stati Uniti d'America 3.608
CN - Cina 890
IE - Irlanda 787
IT - Italia 718
GB - Regno Unito 578
SG - Singapore 496
UA - Ucraina 428
BR - Brasile 231
DE - Germania 231
RU - Federazione Russa 230
CA - Canada 213
SE - Svezia 212
VN - Vietnam 203
HK - Hong Kong 178
TR - Turchia 148
FI - Finlandia 136
FR - Francia 105
BG - Bulgaria 67
KR - Corea 66
IN - India 38
PL - Polonia 34
IL - Israele 33
MX - Messico 33
JP - Giappone 29
CZ - Repubblica Ceca 26
BD - Bangladesh 22
ES - Italia 21
ID - Indonesia 21
NL - Olanda 20
BE - Belgio 18
DK - Danimarca 15
AR - Argentina 14
CH - Svizzera 14
IQ - Iraq 14
TN - Tunisia 12
AU - Australia 10
EU - Europa 10
PK - Pakistan 10
ZA - Sudafrica 10
CL - Cile 9
AT - Austria 8
LT - Lituania 8
SA - Arabia Saudita 8
EG - Egitto 6
RO - Romania 6
CO - Colombia 5
EC - Ecuador 5
GR - Grecia 5
HU - Ungheria 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
VE - Venezuela 5
AL - Albania 4
LK - Sri Lanka 4
MA - Marocco 4
PT - Portogallo 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
PY - Paraguay 3
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CY - Cipro 1
ET - Etiopia 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MN - Mongolia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 10.104
Città #
Dublin 787
Ashburn 390
Chandler 378
Southend 373
Jacksonville 346
Hefei 330
Dallas 272
Singapore 264
Ann Arbor 226
Milan 196
Beijing 173
Toronto 173
Dearborn 171
Hong Kong 169
Dong Ket 135
Salerno 130
New York 105
Wilmington 92
Boston 80
Lawrence 76
Izmir 69
Helsinki 68
Seoul 66
Woodbridge 63
Los Angeles 62
Moscow 54
Boardman 52
Houston 46
Seattle 45
Redwood City 44
Modena 43
Mountain View 43
Fremont 37
Nanjing 34
Rome 34
São Paulo 34
Fairfield 32
Tel Aviv 30
The Dalles 28
Ho Chi Minh City 27
Warsaw 27
Kunming 24
Tokyo 24
Council Bluffs 21
Falls Church 21
Frankfurt am Main 16
Mexico City 16
Ottawa 15
Brussels 14
Chennai 14
Jakarta 14
Jinan 14
London 14
Nuremberg 14
Hanoi 13
Haymarket 13
Munich 13
Denver 12
Montreal 12
Phoenix 12
Santa Clara 12
Stockholm 12
Amsterdam 11
Dammarie 11
Guangzhou 11
Orem 11
Assago 10
Atlanta 10
Auburn Hills 10
Bologna 10
Brooklyn 9
Dhaka 9
Norwalk 9
Wuhan 9
Chengdu 8
Chicago 8
Nanchang 8
Paris 8
Shanghai 8
Torino 8
Falkenstein 7
Johannesburg 7
San Francisco 7
Cairo 6
Cambridge 6
Como 6
Curitiba 6
Fuzhou 6
Mumbai 6
Turin 6
Colombo 5
Fairfax 5
Genoa 5
Lappeenranta 5
Lima 5
Nairobi 5
Palombara Sabina 5
Poplar 5
San Mateo 5
Secaucus 5
Totale 6.405
Nome #
A survival analysis of the last great European plagues: the case of Nonantola (Northern Italy) in 1630 335
Pandemics and socio-economic status : evidence from the plague of 1630 in Northern Italy 326
GiniInc: a Stata package for measuring inequality from incomplete income and survival data 308
The Gini concentration index for the study of survival 217
Neurocognitive assessment in obsessive compulsive disorder patients: adherence to behavioral decision models 203
An analysis of the number of medical malpractice claims and their amounts 194
Clustering-based measurement of dependence 192
A proposal for a two-step sampling design to oversample units responding to prescribed characteristics 173
The Gini Test for Survival Data in Presence of Small and Unbalanced Groups. 168
A bivariate method for spatio-temporal syndromic surveillance 163
Longevity and concentration in survival times: the log-scale-location family of failure time models 159
Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study 157
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial 154
A bivariate method for spatio-temporal syndromic surveillance (article published in proceedings) 149
A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness 147
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness 143
Asymptotic behavior of a set-statistic 142
Biomarkers, subgroup evaluation, and clinical trial design 142
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data 141
The Gini concentration test for survival data 138
Cardiac safety of trastuzumab (H) in combination with pegylated liposomal doxorubicin (D) and docetaxel (T) in HER2-positive metastatic breast cancer (MBC): preliminary results of the Eastern Cooperative Oncology Group Trial E3198 (Abstract) 136
Another STEPP in the right direction 136
Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis 136
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial 135
A nonparametric scoring algorithm for identifying informative genes from microarray data 130
A note on the length-biased Weibull-Gamma frailty survival model 128
M statistic commands: interpoint distance distribution analysis. 126
A permutation test for determining significance of clusters with applications to spatial and gene expression data 126
A new geometric approach to data analysis using the Minkowski polytope 125
Meta-STEPP with random effects 124
Computing the exact distributions of some functions of the ordered multinomial counts: maximum, minimum, range and sums of order statistics 123
Marshall–Olkin frailty survival models for bivariate right-censored failure time data 123
COVID-19 vaccine concerns about safety, effectiveness, and policies in the United States, Canada, Sweden, and Italy among unvaccinated individuals 122
A population-adjusted stable geospatial baseline for outbreak detection in syndromic surveillance (poster with abstract published in proceedings) 121
CEF is superior to CMF for tumours with TOP2A aberrations: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D. 118
Parametric and nonparametric analysis of life courses: an application to family formation patterns 117
Interpoint distance distribution 117
Parametric modelling of interpoint distance distributions, with an application to a mixture model for biosurveillance data 117
Risk factors for locoregional recurrence among breast cancer patients: Results from international breast cancer study group trials I through VII 116
Tailoring adjuvant treatments for the individual breast cancer patient 115
Patterns of treatment effects in subsets of patients in clinical trials 113
Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF 111
Lorenz Curves and Treatment-Covariate Interactions in Clinical Trials 109
Modelling menstrual status during and after adjuvant treatment for breast cancer 109
The Gini Concentration Test for Survival Data 109
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII 108
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP 108
The interpoint distance distribution as a descriptor of point patterns, with an application to cluster detection 107
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes 107
Real time spatial cluster detection using interpoint distances among precise patient locations 106
A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival data. 106
MAX2 - A convenient index to estimate the average per patient risk for chemotherapy toxicity: Validation in ECOG trials 105
Evaluating markers for guiding treatment 105
Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment-Effect Pattern Plot (STEPP). 104
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study 102
MAX2: a convenient index to estimate the average per patient risk of severe toxicity from a chemotherapy regimen. Testing in ECOG studies (Abstract) 101
Deformable templates: a statistical setting 100
The choice of the number of bins for the M statistic 100
Discussion of the Frangakis and Rubin article 100
Prognostic Value of Extracapsular Tumor Spread for Locoregional Control in Premenopausal Patients With Node-Positive Breast Cancer Treated With Classical Cyclophosphamide, Methotrexate, and Fluorouracil: Long-Term Observations From International Breast Cancer Study Group Trial VI 100
The distribution of interpoint distances 99
Linking excess mortality to mobility data during the first wave of COVID-19 in England and Wales 98
Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy 95
Distance-based methods for spatial and spatio-temporal surveillance 95
Enhanced power to detect bioterrorism with spatial clustering (abstract) 94
Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis results from the Roxbury Lupus Project 94
Invited review of article: Jiang, Runchao; Lu, Wenbin; Song, Rui; Davidian, Marie (2017). On estimation of optimal treatment regimes for maximizing t-year survival probability. R. Stat. Soc. Ser. B. Stat. Methodol. 79 (2017), no. 4, 1165–1185. 93
Power comparisons for an improved disease clustering test 92
Principles of clinical trials 92
Cross-national vaccine concerns and predictors of vaccine hesitancy in not-fully vaccinated individuals: findings from USA, Canada, Sweden, and Italy 92
Parametric models for interpoint distances and their use in biosurveillance 91
Identifying breast cancer patients at high risk for bone metastases 90
Freedom of choice to vaccinate and COVID-19 vaccine hesitancy in Italy 89
The use of multiple addresses to enhance cluster detection 87
Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors 86
Features that predict responsiveness to chemotherapy and endocrine therapies 84
Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial 83
Epilocal: a real-time tool for local epidemic monitoring 82
Subpopulation Treatment Effect Pattern Plot (STEPP) methods with R and Stata 76
Evaluation of age-specific causes of death in the context of the Italian longevity transition 74
The sparsity index in Poisson size-biased sampling: algorithms for the optimal unbiased estimation from small samples 55
The average uneven mortality index: building on the "e-dagger" measure of lifespan inequality 47
Totale 10.240
Categoria #
all - tutte 47.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021703 0 0 0 0 0 88 100 72 108 47 89 199
2021/2022764 85 208 12 18 32 38 35 71 56 55 84 70
2022/20231.861 85 44 35 119 143 117 60 110 991 29 77 51
2023/2024911 48 41 56 13 109 119 77 103 41 39 119 146
2024/20251.307 34 33 58 26 63 40 178 71 442 126 129 107
2025/20261.908 338 564 175 355 405 71 0 0 0 0 0 0
Totale 10.240